comparemela.com

Latest Breaking News On - Zentalis pharmaceuticals company profile - Page 1 : comparemela.com

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9 48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9 48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Insider Selling: Zentalis Pharmaceuticals, Inc (NASDAQ:ZNTL) CFO Sells 9,597 Shares of Stock

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $11.98, for a total transaction of $114,972.06. Following the transaction, the chief financial officer now owns 633,680 shares in the company, […]

Zentalis Pharmaceuticals, Inc (NASDAQ:ZNTL) Receives Consensus Rating of Moderate Buy from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target among […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.